Release Date: 26/02/20 08:21 Summary: Revenue Guidance for Q1 2020 Price Sensitive: Yes Download Document 189.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%